Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification

Journal of Pathology

Volumn 242, Issue 1, 2017, Pages 113-125

  Sjödahl, Gottfrid ^a   Eriksson, Pontus ^a   Liedberg, Fredrik ^a   Höglund, Mattias ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

bladder cancer; molecular classification; pseudo differentiation; tumour cell phenotypes

Indexed keywords

MESSENGER RNA; RNA; TRANSCRIPTOME; TUMOR MARKER; TUMOR PROTEIN;

ADVANCED CANCER; ARTICLE; BASAL CELL CARCINOMA; CANCER CLASSIFICATION; CYSTECTOMY; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESENCHYME; MOLECULAR PATHOLOGY; MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; TUMOR CELL; TUMOR INVASION; BLADDER TUMOR; CANCER GRADING; CANCER STAGING; CELL DIFFERENTIATION; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE;

BIOMARKERS, TUMOR; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PHENOTYPE; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTOME; URINARY BLADDER NEOPLASMS;

EID: 85017121084     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4886     Document Type: Article

References (29)

1. Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869–10874.
2. Hayes DN, Monti S, Parmigiani G, et al. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. J Clin Oncol 2006; 24: 5079–5090.
3. Marisa L, de Reyniès A, Duval A, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med 2013; 10: e1001453.
4. Lerner SP, McConkey DJ, Hoadley KA, et al. Bladder cancer molecular taxonomy: summary from a consensus meeting. Bladder Cancer 2016; 2: 37–47.
5. Lindgren D, Sjödahl G, Lauss M, et al. Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma. PLoS One 2012; 7: e38863.
6. Patschan O, Sjödahl G, Chebil G, et al. A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma. Eur Urol 2015; 68: 824–832; discussion 835-836.
7. Sjödahl G, Lauss M, Lövgren K, et al. A molecular taxonomy for urothelial carcinoma. Clin Cancer Res 2012; 18: 3377–3386.
8. Sjödahl G, Lövgren K, Lauss M, et al. Toward a molecular pathologic classification of urothelial carcinoma. Am J Pathol 2013; 183: 681–691.
9. Choi W, Porten S, Kim S, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 2014; 25: 152–165.
10. Damrauer JS, Hoadley KA, Chism DD, et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc Natl Acad Sci USA 2014; 111: 3110–3115.
11. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014; 507: 315–322.
12. Rebouissou S, Bernard-Pierrot I, de Reyniès A, et al. EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype. Sci Transl Med 2014; 6: 244ra291.
13. Hedegaard J, Lamy P, Nordentoft I, et al. Comprehensive transcriptional analysis of early-stage urothelial carcinoma. Cancer Cell 2016; 30: 27–42.
14. Aine M, Eriksson P, Liedberg F, et al. Biological determinants of bladder cancer gene expression subtypes. Sci Rep 2015; 5: 10957.
15. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 8: 118–127.
16. Fernández-Acenero MJ, Cordova S, Manzarbeitia F, et al. Immunohistochemical profile of urothelial and small cell carcinomas of the bladder. Pathol Oncol Res 2011; 17: 519–523.
17. Varley CL, Stahlschmidt J, Smith B, et al. Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells. Am J Pathol 2004; 164: 1789–1798.
18. Varley CL, Bacon EJ, Holder JC, et al. FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation. Cell Death Differ 2009; 16: 103–114.
19. Mauney JR, Ramachandran A, Yu RN, et al. All-trans retinoic acid directs urothelial specification of murine embryonic stem cells via GATA4/6 signaling mechanisms. PLoS One 2010; 5: e11513.
20. DeGraff DJ, Cates JM, Mauney JR, et al. When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression. Urol Oncol 2013; 31: 802–811.
21. Böck M, Hinley J, Schmitt C, et al. Identification of ELF3 as an early transcriptional regulator of human urothelium. Dev Biol 2014; 386: 321–330.
22. Jimenez RE, Gheiler E, Oskanian P, et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 2000; 24: 980–987.
23. Eriksson P, Aine M, Veerla S, et al. Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems. BMC Med Genomics 2015; 8: 25.
24. Harnden P, Allam A, Joyce AD, et al. Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent disease. Histopathology 1995; 27: 169–174.
25. Wu RL, Osman I, Wu XR, et al. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Res 1998; 58: 1291–1297.
26. Kim WJ, Kim EJ, Kim SK, et al. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol Cancer 2010; 9: 3.
27. Blaveri E, Simko JP, Korkola JE, et al. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 2005; 11: 4044–4055.
28. GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 2015; 348: 648–660.
29. Moch H, Humphrey PA, Ulbright TM, et al. (eds). World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2016.